The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Nuclear factor e2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer

  • Kim, Young-Sun (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Lee, Hye-Lim (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Lee, Ki-Bum (Department of Anatomical Pathology, Ajou University School of Medicine) ;
  • Park, Joo-Hun (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Chung, Wou-Young (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Lee, Keu-Sung (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Sheen, Seung-Soo (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Park, Kwang-Joo (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Hwang, Sung-Chul (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine)
  • Published : 2011.09.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Oxidative stress results in protein oxidation and is implicated in carcinogenesis. Sulfiredoxin (Srx) is responsible for the enzymatic reversal of inactivated peroxiredoxin (Prx). Nuclear factor E2-related factor 2 (Nrf2) binds to antioxidant responsive elements and upregulates the expression of Srx and Prx during oxidative stress. We aimed to elucidate the biological functions and potential roles of Srx in lung cancer. Methods: To study the roles of Srx and Prx III in lung cancer, we compared the protein levels of Nrf2, Prxs, thioredoxin, and Srx in 40 surgically resected human lung cancer tissues using immunoblot and immunohistochemical analyses. Transforming growth factor-${\beta}_1$, tumor necrosis factor-${\alpha}$, and camptothecin treatment were used to examine Prx III inactivation in Mv1Lu mink lung epithelial cells and A549 lung cancer cells. Results: Prx I and Prx III proteins were markedly overexpressed in lung cancer tissues. A significant increase in the oxidized form of a cysteine sulfhydryl at the catalytic site of Prxs was found in carcinogenic lung tissue compared to normal lung tissue. Densitometric analyses of immunoblot data revealed significant Srx expression, which was higher in squamous cell carcinoma tissue (60%, 12/20) than in adenocarcinoma (20%, 4/20). Also, Nrf2 was present in the nuclear compartment of cancer cells. Conclusions: Srx and Prx III proteins were markedly overexpressed in human squamous cell carcinoma, suggesting that these proteins may play a protective role against oxidative injury and compensate for the high rate of mitochondrial metabolism in lung cancer.

Keywords

References

  1. Rhee SG. Cell signaling: H2O2, a necessary evil for cell signaling. Science 2006;312:1882-1883. https://doi.org/10.1126/science.1130481
  2. Chowdhury I, Mo Y, Gao L, Kazi A, Fisher AB, Feinstein SI. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic Biol Med 2009;46:146-153. https://doi.org/10.1016/j.freeradbiomed.2008.09.027
  3. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998;273:6297-6302. https://doi.org/10.1074/jbc.273.11.6297
  4. Kang SW, Rhee SG, Chang TS, Jeong W, Choi MH. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 2005;11:571-578. https://doi.org/10.1016/j.molmed.2005.10.006
  5. Chang TS, Jeong W, Woo HA, Lee SM, Park S, Rhee SG. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem 2004;279:50994-51001. https://doi.org/10.1074/jbc.M409482200
  6. Lei K, Townsend DM, Tew KD. Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response. Oncogene 2008;27:4877-4887. https://doi.org/10.1038/onc.2008.132
  7. Rhee SG, Jeong W, Chang TS, Woo HA. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int Suppl 2007;(106):S3-S8.
  8. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 2003;23:8786-8794. https://doi.org/10.1128/MCB.23.23.8786-8794.2003
  9. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res 2008;58:262-270. https://doi.org/10.1016/j.phrs.2008.09.003
  10. Cho HY, Jedlicka AE, Reddy SP, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002;26:175-182. https://doi.org/10.1165/ajrcmb.26.2.4501
  11. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116. https://doi.org/10.1146/annurev.pharmtox.46.120604.141046
  12. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 2006;8:76-87. https://doi.org/10.1089/ars.2006.8.76
  13. Colburn NH, Kensler TW. Targeting transcription factors for cancer prevention: the case of Nrf2. Cancer Prev Res (Phila) 2008;1:153-155. https://doi.org/10.1158/1940-6207.CAPR-08-0025
  14. Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med 2001;7:135-145.
  15. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002;22:2883-2892. https://doi.org/10.1128/MCB.22.9.2883-2892.2002
  16. Osburn WO, Kensler TW. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res 2008;659:31-39. https://doi.org/10.1016/j.mrrev.2007.11.006
  17. Park JJ, Chang HW, Jeong EJ, et al. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009;73:1196-1202. https://doi.org/10.1016/j.ijrobp.2008.10.070
  18. Stacy DR, Ely K, Massion PP, et al. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 2006;28:813-818. https://doi.org/10.1002/hed.20430
  19. Park JH, Kim YS, Lee HL, et al. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 2006;11:269-275. https://doi.org/10.1111/j.1440-1843.2006.00849.x
  20. Bae SH, Woo HA, Sung SH, et al. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid Redox Signal 2009;11:937-948. https://doi.org/10.1089/ars.2008.2325
  21. Findlay VJ, Tapiero H, Townsend DM. Sulfiredoxin: a potential therapeutic agent? Biomed Pharmacother 2005;59:374-379. https://doi.org/10.1016/j.biopha.2005.07.003
  22. Jeong W, Park SJ, Chang TS, Lee DY, Rhee SG. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J Biol Chem 2006;281:14400-14407. https://doi.org/10.1074/jbc.M511082200
  23. Noh YH, Baek JY, Jeong W, Rhee SG, Chang TS. Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem 2009;284:8470-8477. https://doi.org/10.1074/jbc.M808981200
  24. Soriano FX, Baxter P, Murray LM, Sporn MB, Gillingwater TH, Hardingham GE. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol Cells 2009;27:279-282. https://doi.org/10.1007/s10059-009-0050-y
  25. Woo HA, Jeong W, Chang TS, et al. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 2005;280:3125-3128. https://doi.org/10.1074/jbc.C400496200
  26. Hubner RH, Schwartz JD, De Bishnu P, et al. Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking. Mol Med 2009;15:203-219. https://doi.org/10.1007/s00894-008-0395-8
  27. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008;2:351-374. https://doi.org/10.1177/1753465808098224
  28. Singh A, Ling G, Suhasini AN, et al. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 2009;46:376-386. https://doi.org/10.1016/j.freeradbiomed.2008.10.026
  29. Shibata T, Kokubu A, Gotoh M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008;135:1358-1368. https://doi.org/10.1053/j.gastro.2008.06.082

Cited by

  1. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression vol.53, pp.3, 2012, https://doi.org/10.1016/j.freeradbiomed.2012.05.020
  2. Prx I Suppresses K-ras-Driven Lung Tumorigenesis by Opposing Redox-Sensitive ERK/Cyclin D1 Pathway vol.19, pp.5, 2011, https://doi.org/10.1089/ars.2011.4421
  3. siRNA targeting of PRDX3 enhances cisplatin-induced apoptosis in ovarian cancer cells through the suppression of the NF-κB signaling pathway vol.7, pp.5, 2011, https://doi.org/10.3892/mmr.2013.1370
  4. Thioredoxins, Glutaredoxins, and Peroxiredoxins-Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling vol.19, pp.13, 2013, https://doi.org/10.1089/ars.2012.4599
  5. Role of sulfiredoxin in systemic diseases influenced by oxidative stress vol.2, pp.None, 2011, https://doi.org/10.1016/j.redox.2014.09.002
  6. Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome vol.25, pp.3, 2011, https://doi.org/10.1038/jes.2014.16
  7. Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression vol.6, pp.26, 2011, https://doi.org/10.18632/oncotarget.4192
  8. Hydrogen peroxide – production, fate and role in redox signaling of tumor cells vol.13, pp.1, 2011, https://doi.org/10.1186/s12964-015-0118-6
  9. Downregulation of peroxiredoxin-3 by hydrophobic bile acid induces mitochondrial dysfunction and cellular senescence in human trophoblasts vol.6, pp.None, 2011, https://doi.org/10.1038/srep38946
  10. Activation of the Nrf2-Keap 1 Pathway in Short-Term Iodide Excess in Thyroid in Rats vol.2017, pp.None, 2011, https://doi.org/10.1155/2017/4383652
  11. Redox Regulation of Inflammatory Processes Is Enzymatically Controlled vol.2017, pp.None, 2011, https://doi.org/10.1155/2017/8459402
  12. Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma vol.8, pp.2, 2011, https://doi.org/10.18632/oncotarget.13838
  13. The role of peroxiredoxins in cancer vol.6, pp.2, 2011, https://doi.org/10.3892/mco.2017.1129
  14. Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway vol.18, pp.5, 2011, https://doi.org/10.3390/ijms18050917
  15. Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer vol.28, pp.7, 2011, https://doi.org/10.1089/ars.2017.7422
  16. Increased Sulfiredoxin Expression in Gastric Cancer Cells May Be a Molecular Target of the Anticancer Component Diallyl Trisulfide vol.2019, pp.None, 2011, https://doi.org/10.1155/2019/4636804
  17. Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis vol.84, pp.2, 2011, https://doi.org/10.1134/s0006297919020019
  18. Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors vol.20, pp.10, 2011, https://doi.org/10.3390/ijms20102531
  19. Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential vol.10, pp.5, 2011, https://doi.org/10.1111/1759-7714.13052
  20. The redox regulator sulfiredoxin forms a complex with thioredoxin domain–containing 5 protein in response to ER stress in lung cancer cells vol.294, pp.22, 2011, https://doi.org/10.1074/jbc.ra118.005804
  21. Frugoside Induces Mitochondria-Mediated Apoptotic Cell Death through Inhibition of Sulfiredoxin Expression in Melanoma Cells vol.11, pp.6, 2019, https://doi.org/10.3390/cancers11060854
  22. The Role of Peroxiredoxin Family in Cancer Signaling vol.24, pp.2, 2019, https://doi.org/10.15430/jcp.2019.24.2.65
  23. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer vol.10, pp.1, 2011, https://doi.org/10.3390/biom10010135
  24. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies vol.9, pp.11, 2011, https://doi.org/10.3390/antiox9111151
  25. Peroxiredoxins—The Underrated Actors during Virus-Induced Oxidative Stress vol.10, pp.6, 2011, https://doi.org/10.3390/antiox10060977